Edition:
United States

Genomic Health Inc (GHDX.O)

GHDX.O on Nasdaq

32.94USD
21 Jul 2017
Change (% chg)

$-0.28 (-0.84%)
Prev Close
$33.22
Open
$33.46
Day's High
$33.46
Day's Low
$32.70
Volume
77,900
Avg. Vol
113,212
52-wk High
$33.97
52-wk Low
$25.66

Latest Key Developments (Source: Significant Developments)

Genomic Health Q1 revenue $84 million
Tuesday, 9 May 2017 04:05pm EDT 

May 9 (Reuters) - Genomic Health Inc ::Genomic Health announces first quarter 2017 financial results and reports recent business progress.Q1 loss per share $0.02.Q1 revenue $84 million versus I/B/E/S view $86.2 million.Q1 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S.Says international product revenue was $13.4 million in Q1 of 2017, compared with $10.4 million in Q1 of 2016.Says U.S. product revenue was $70.6 million in Q1 of 2017, compared with $70.5 million in Q1 of 2016.  Full Article

Genomic Health says may sell up to 13.7 mln shares
Thursday, 11 Aug 2016 05:34pm EDT 

Genomic Health Inc : Says may sell up to an aggregate of 13.7 million shares of common stock - SEC filing .Shares being offered by selling stockholders, co will not receive any proceeds from the sale.  Full Article

Genomic Health files for mixed shelf of up to $350 mln - SEC filing
Thursday, 11 Aug 2016 04:15pm EDT 

Genomic Health Inc : Files for mixed shelf of up to $350 million - SEC filing Source: (http://bit.ly/2b0l97v ) Further company coverage: [GHDX.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Genomic Health posts Q2 loss per share $0.18
Tuesday, 2 Aug 2016 04:05pm EDT 

Genomic Health Inc : Q2 loss per share $0.18 . Q2 revenue $82 million versus $70.6 million . Is raising low end of both revenue and test guidance for full-year ending December 31, 2016 . Maintaining net loss guidance between $12 and $18 million at mid-point of revenue guidance, excluding items for 2016 . FY2016 earnings per share view $-0.45, revenue view $330.3 million -- Thomson Reuters I/B/E/S . Q2 earnings per share view $-0.18, revenue view $81.3 million -- Thomson Reuters I/B/E/S . Raising total revenue to between $325 and $335 million for 2016 .Sees 2016 basic net loss per share of between $0.37 and $0.55.  Full Article

Genomic Health Inc raises FY 2015 guidance
Tuesday, 4 Aug 2015 04:07pm EDT 

Genomic Health Inc:Expects FY 2015 revenue of $289 to $302 million (formerly $292 to $305 million).Expects FY 2015 Net loss between $19 and $26 million (formerly $17 and $24 million), or basic net loss per share of between $0.59 and $0.81.FY 2015 revenue of $294 million and net income of $(23) million - Thomson Reuters I/B/E/S.  Full Article

BRIEF-Genomic Health Q1 revenue $84 million

* Genomic Health announces first quarter 2017 financial results and reports recent business progress